Metropolitan Life Insurance Company (MetLife)’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-12,244	Closed	-$155K	–	2726
2014 Q3	$155K	Hold	12,244	–	–	﹤0.01%	2538
2014 Q2	$209K	Buy	12,244 +478	+4%	+$7.12K	﹤0.01%	2481
2014 Q1	$158K	Buy	+11,766	New	+$154K	﹤0.01%	2593

Metropolitan Life Insurance Company (MetLife)'s DRTX Position: Q4 2014 in Review

Metropolitan Life Insurance Company (MetLife) sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 12,244 shares — an estimated $155K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DRTX in Q1 2014 and held it in 3 quarters. The position peaked at $209K in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

Metropolitan Life Insurance Company (MetLife) reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 12,244 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $155K.
Metropolitan Life Insurance Company (MetLife) first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 3 quarters.
Metropolitan Life Insurance Company (MetLife)'s DURATA THERAPEUTICS INC COM STK (DE) position peaked at $209K in Q2 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2014, filed 4 Feb 2015.